BIO-TECHNE Corp — Director's Dealing 2020

Aug 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-08-05

Reporting Person: Hippel James (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-05	Restricted Stock Units	$	A	3219	Acquired		Common Stock (3219)	Direct
2020-08-05	Stock Options (Right to Buy)	$267.87	A	14360	Acquired	2027-08-05	Common Stock (14360)	Direct
2020-08-05	Stock Options (Right to Buy)	$267.87	A	19147	Acquired	2027-08-05	Common Stock (19147)	Direct
2020-08-05	Stock Options (Right to Buy)	$267.87	A	8325	Acquired	2027-08-05	Common Stock (8325)	Direct
2020-08-05	Stock Options (Right to Buy)	$267.87	A	8325.0	Acquired	2027-08-05	Common Stock (8325.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6883	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$108.49	2022-08-07	Common Stock (15909)	15909	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (30400)	30400	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (40533)	40533	Direct
Restricted Stock Units	$		Common Stock (4438)	4438	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (24460)	24460	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (32613)	32613	Direct
Restricted Stock Units	$		Common Stock (3383)	3383	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (18066)	18066	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (24089)	24089	Direct
Restricted Stock Units	$		Common Stock (3938)	3938	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (19936)	19936	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (26581)	26581	Direct

Footnotes

F1: Reflects a correction to the previously-reported number.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

F3: Fully exercisable.

F4: Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020.

F5: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021.

F7: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F8: Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.

F9: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F10: Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.

F11: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F12: Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.

F13: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.

F14: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021